BindingDB logo
myBDB logout

18 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28337320 21 Discovery and Assessment of Atropisomers of ()-Lesinurad.EBI WuXi AppTec
26704267 35 Discovery of potent and orally bioavailable inhibitors of Human Uric Acid Transporter 1 (hURAT1) and binding mode prediction using homology model.EBI Shanghai Hengrui Pharmaceutical Co., Ltd
17325024 6 Morin (3,5,7,2',4'-pentahydroxyflavone) exhibits potent inhibitory actions on urate transport by the human urate anion transporter (hURAT1) expressed in human embryonic kidney cells.EBI The Chinese University of Hong Kong
21449597 26 Developing potent human uric acid transporter 1 (hURAT1) inhibitors.EBI University of Colorado Anschutz Medical Campus
28351592 27 Synthesis and evaluation of sulfonamide derivatives as potent Human Uric Acid Transporter 1 (hURAT1) inhibitors.EBI Chinese Academy of Sciences
 8 Synthesis,MolecularModeling, and Biological Evaluation of Novel Tetrahydro--Carboline Hydantoin and Tetrahydro--Carboline Thiohydantoin Derivatives as Phosphodiesterase 5 InhibitorsBDB German University in Cairo
18487044 16 Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.BDB Anadys Pharmaceuticals
19173605 18 Extra Binding Region Induced by Non-Zinc Chelating Inhibitors into the S(1)' Subsite of Matrix Metalloproteinase 8 (MMP-8) (dagger).BDB Universita degli Studi
15044733 4 Inhibitor binding in a class 2 dihydroorotate dehydrogenase causes variations in the membrane-associated N-terminal domain.BDB University of Copenhagen
14561090 21 Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase.BDB Roche Palo Alto LLC
17276063 38 Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit.BDB Abbott Laboratories